Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Topotecan and Cisplatin with Radiation in Cervical Cancer
NCT00257816Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Jan 2004
- Primary completion
- Dec 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan liposome in Cervical Cancer (CC), sponsored by University of California, Irvine. Primary endpoints: Feasibility of administering weekly Topotecan, Toxicity of administering weekly Topotecan and 1 more. Started Jan 2004; status: completed.
02
Drugs
topotecan liposome
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00257816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257816.